Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06584929 · ClinicalTrials.gov registry record · NA
Rural Smoking Cessation
A NA study, sponsored by Masonic Cancer Center, University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 272
- Enrollment target
NCT06584929: Recruiting NA study, sponsored by Masonic Cancer Center, University of Minnesota.
NCT06584929 is a NA study that is actively recruiting participants, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 272 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06584929, a NA study, is actively recruiting participants, sponsored by Masonic Cancer Center, University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 272 participants
- Enrollment target
Study Summary
Understanding ways to help people who live in rural areas quit smoking is a public health priority. quitting smoking among rural people who smoke is a critical public health concern. People in rural areas smoke at higher rates than those in urban areas, experience high rates of smoking caused cancers and deaths. We are recruiting rural people from around the country to better understand how different quit smoking methods can improve a person's chances of successfully quitting smoking.
Primary Outcome
Biochemically-confirmed 7-day abstinence from all combustible tobacco products at 3 months.
Interventions
- DRUG Nicoderm CQ nicotine patch
- DRUG Nicorette Nicotine Lozenges
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2026-03-17 |
| Est. Completion | 2029-08-31 |
| Phase | NA |
What NCT06584929 shows while recruiting
NCT06584929 is an interventional study that assigns participants to a tested intervention. The registered 272 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which Nicoderm CQ nicotine patch is the first listed.
NCT06584929 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06584929 about?
NCT06584929 is a clinical study titled "Rural Smoking Cessation". Understanding ways to help people who live in rural areas quit smoking is a public health priority. quitting smoking among rural people who smoke is a critical public health concern. People in rural areas smoke at higher rates than those in urban areas, experience high rates of smoking caused cancer...
What is the current status of trial NCT06584929?
This trial is currently recruiting. It is a NA study. The enrollment target is 272 participants. The study started on 2026-03-17. Estimated completion is 2029-08-31.
What interventions are being tested in trial NCT06584929?
The interventions under investigation include: Nicoderm CQ nicotine patch (DRUG), Nicorette Nicotine Lozenges (DRUG).
Who is sponsoring clinical trial NCT06584929?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06584929's enrollment target sits among peer trials
272 387th of 2000 higher than 1,614 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02468024 · 272 participants · Phase 3
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- NCT05519449 · 272 participants · Phase 1
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- NCT06035939 · 272 participants · NA
SMYLS Multi-site Trial
- NCT06083051 · 272 participants · NA
Differences in Postoperative Symptoms With Four Ureteral Stents
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI